People who have had COVID will still benefit from having a COVID vaccine. Here’s why.
Articles on COVID-19 vaccines
Displaying 381 - 400 of 596 articles
Early test results look promising, and Pfizer has asked the FDA to review and authorize its vaccine for use in teens. That doesn’t mean putting away the face masks, though.
Scientists around the world are trying to come up with universal coronavirus vaccines to combat the emergence of variants. But what are these vaccines and are they even possible?
This group has long suffered much higher death rates than the general population due to a poor standard of basic healthcare.
From today, around 1,000 clinics around the country can begin vaccinating eligible Australians.
Solar-powered cold chain technologies can be game-changers in the fight against COVID-19 in resource-limited settings in sub-Saharan Africa and beyond.
Supply chain issues can be addressed – but the issues with the AstraZeneca vaccine are political, too.
The European Medicines Agency has said the Oxford/AstraZeneca vaccine is not associated with an increased overall risk of developing blood clots.
As immunisation emerges as the world’s primary weapon to combat COVID-19, much more work is needed to improve electricity access so vaccines can be refrigerated.
It’s not too late for Australia to repair our vaccine strategy, though we will never make up for the months lost.
Divisions among Catholics have created doubts about the moral acceptability of one of the COVID-19 vaccines. An expert explains why there isn’t one ‘Catholic view’ on the issue.
The government should be explicit about what proportion of the population will need to be vaccinated to warrant border reopening. Australians could then measure progress towards that goal.
Decades of experience with influenza offers insights into how we should handle new SARS-CoV-2 variants, and the threat they pose to vaccine effectiveness.
A vaccination queue-jumping scandal in Peru has caused a massive uproar in the South American country. It could also be a wake-up call for all nations.
Several countries on the continent had introduced COVID-19 vaccination by early March 2021.
Is Australia behind on its rollout of the COVID-19 vaccine? Yes. Will it catch up? Most likely, yes. But there are perils in trying to go too fast, and in overpromising on deadlines.
Data from clinical trials and the real world COVID vaccine rollout suggest blood clots occur no more frequently in vaccinated people than they do in the general population.
The risk of COVID escaping from hotel quarantine or a health-care setting will never be zero. But in NSW and Queensland, was everything possible done to minimise the risk?
An out-of-control COVID epidemic in PNG would be a humanitarian and economic disaster for the nation itself, and a grave threat to the region.
The group has been at pains to stress it is not fundamentally about countering the ‘Chinese threat’. But of course, that is primarily what it is about.
Top contributors
-
Professor, School of Population Health, UNSW
-
Professor, The Children's Hospital at Westmead Clinical School and Sydney Infectious Diseases Institute, University of Sydney
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Professor of Paediatrics and vaccinologist, Royal Childrens Hospital, University of Melbourne and Murdoch Childrens Research Institute (MCRI); Associate Dean International, University of Melbourne, Murdoch Children's Research Institute
-
Professor, School of Social Sciences, The University of Western Australia
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Associate Professor, Epidemiology, Deakin University
-
Associate Professor of Health Law, Policy and Management, Boston University
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Chair in Epidemiology, Deakin University
-
Distinguished Professor, Professor of Immunology, RMIT University
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Instructor of Human Immunology, Emory University